Extended Data Fig. 2: Swimmer plot. | Nature Medicine

Extended Data Fig. 2: Swimmer plot.

From: Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial

Extended Data Fig. 2

Duration of treatment and treatment responses in the PP population. The length of the bars represent the time from randomization to disease progression (iRECIST) or censoring. Symbols denote the first time a treatment response (other than progression) is documented, patients censored for progression, and the last date of study treatment.

Back to article page